Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 42.04M | $ 7.87M | 18.71% |
3/31/2025 | $ 50.11M | $ 14.01M | 27.95% |
12/31/2024 | $ 63.2M | $ 24.57M | 38.88% |
9/30/2024 | $ 91.81M | $ 29.59M | 32.23% |
6/30/2024 | $ 93.68M | $ 26.82M | 28.63% |
3/31/2024 | $ 90.03M | $ 23.34M | 25.92% |
12/31/2023 | $ 91.93M | $ 21.38M | 23.26% |
9/30/2023 | $ 91.71M | $ 18.87M | 20.57% |
6/30/2023 | $ 91.06M | $ 16.49M | 18.11% |
3/31/2023 | $ 95.37M | $ 14.1M | 14.79% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for PROPHASE LABS INC is calculated as follows: Debt [ $ 9.99M ] / Assets [ $ 23.03M ]
(=) Debt to Assets [ 43.37% ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |